Skip to main content
. 2021 Dec 4;12(2):10799–10811. doi: 10.1080/21655979.2021.2003931

Figure 5.

Figure 5.

Verification in clinical samples. (a) SERPINA1 mRNA expression in active tuberculosis, latent tuberculosis infection and healthy controls; (b) FUCA2 mRNA expression in active tuberculosis, latent tuberculosis infection and healthy controls; (c) HP mRNA expression in active tuberculosis, latent tuberculosis infection and healthy controls; *represents P < 0.05; ** represents P < 0.01; ***represents P < 0.001; ATB: active tuberculosis, LTBI: latent tuberculosis infection, HC: healthy control. Nonparametric one-way ANOVA(Kruskal-Walls) analyses were performed on measurement of mRNA expression levels